Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael B Stricker

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|March 31, 2012
Risk of malignancy associated with Lyme disease: still up in the airRaphael B Stricker, Lorraine Johnson
Expert Review of Anti-Infective Therapy|October 5, 2007
Lyme disease: a turning pointRaphael B Stricker, Lorraine Johnson
The American Journal of Medicine|July 31, 2010
Persistent symptoms following treatment of early Lyme disease: false hope?Raphael B Stricker, Lorraine Johnson
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 3, 2010
The Lyme disease chronicles, continued. Chronic Lyme disease: in defense of the patient enterpriseRaphael B Stricker, Lorraine Johnson
Frontiers in Cellular and Infection Microbiology|August 23, 2013
Borrelia burgdorferi aggrecanase activity: more evidence for persistent infection in Lyme diseaseRaphael B Stricker, Lorraine Johnson
Philosophy, Ethics, and Humanities in Medicine : PEHM|June 10, 2010
The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guidelinesLorraine Johnson, Raphael B Stricker
Expert Review of Anti-Infective Therapy|October 16, 2004
Treatment of Lyme disease: a medicolegal assessmentLorraine Johnson, Raphael B Stricker
Brain, Behavior, and Immunity|April 27, 2010
Letter to the editor re "Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms" by Chandra et alRaphael B Stricker, Lorraine Johnson
Southern Medical Journal|October 1, 2003
Is cholesterol lowering with statins the gold standard for treating patients with cardiovascular risk and disease?Raphael B Stricker, Billi Goldberg
Expert Opinion on Investigational Drugs|October 2, 2003
The Lyme Wars: time to listenRaphael B Stricker, Andrew Lautin
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|March 31, 2012
Risk of malignancy associated with Lyme disease: still up in the airRaphael B Stricker, Lorraine Johnson
Expert Review of Anti-Infective Therapy|October 5, 2007
Lyme disease: a turning pointRaphael B Stricker, Lorraine Johnson
The American Journal of Medicine|July 31, 2010
Persistent symptoms following treatment of early Lyme disease: false hope?Raphael B Stricker, Lorraine Johnson
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 3, 2010
The Lyme disease chronicles, continued. Chronic Lyme disease: in defense of the patient enterpriseRaphael B Stricker, Lorraine Johnson
Frontiers in Cellular and Infection Microbiology|August 23, 2013
Borrelia burgdorferi aggrecanase activity: more evidence for persistent infection in Lyme diseaseRaphael B Stricker, Lorraine Johnson
Philosophy, Ethics, and Humanities in Medicine : PEHM|June 10, 2010
The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guidelinesLorraine Johnson, Raphael B Stricker
Expert Review of Anti-Infective Therapy|October 16, 2004
Treatment of Lyme disease: a medicolegal assessmentLorraine Johnson, Raphael B Stricker
Brain, Behavior, and Immunity|April 27, 2010
Letter to the editor re "Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms" by Chandra et alRaphael B Stricker, Lorraine Johnson
Southern Medical Journal|October 1, 2003
Is cholesterol lowering with statins the gold standard for treating patients with cardiovascular risk and disease?Raphael B Stricker, Billi Goldberg
Expert Opinion on Investigational Drugs|October 2, 2003
The Lyme Wars: time to listenRaphael B Stricker, Andrew Lautin
Pageof 10